MPM Oncology Impact Management »

Avidity Biosciences Ord shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.1M 125k 40.85

More positions owned by MPM Oncology Impact Management

Cullinan Therapeutics Common (CGEM)
Insmed Incorporated Common (INSM)
Olema Pharmaceuticals Common (OLMA)
iTeos Therapeutics Common (ITOS)
Crinetics Pharmaceuticals Common (CRNX)
Madrigal Pharmaceuticals Common (MDGL)
Iovance Biotherapeutics Common (IOVA)
Natera Common (NTRA)
Mirum Pharmaceuticals Common (MIRM)
Ultragenyx Pharmaceutical Common (RARE)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Guardant Health Common (GH)
Disc Medicine Common (IRON)
Alkermes Common (ALKS)
Edgewise Therapeutics Common (EWTX)

View all positions for MPM Oncology Impact Management

Top funds holding Avidity Biosciences Ord

T. Rowe Price Associates
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
State Street Corporation
Geode Capital Management
Casdin Capital
Boxer Capital
Siren
Bank of America Corporation
Artisan Partners Limited Partnership
Morgan Stanley
Nuveen Asset Management

View all funds holding Avidity Biosciences Ord